A CASE SERIES: AYURVEDIC MANAGEMENT OF TAMAKA SHVASA (BRONCHIAL ASTHMA)

Global journal for research analysis Pub Date : 2024-01-15 DOI:10.36106/gjra/6705981

Minal Manoharrao Khode, Suryaprakash Jaiswal

{"title":"A CASE SERIES: AYURVEDIC MANAGEMENT OF TAMAKA SHVASA (BRONCHIAL ASTHMA)","authors":"Minal Manoharrao Khode, Suryaprakash Jaiswal","doi":"10.36106/gjra/6705981","DOIUrl":null,"url":null,"abstract":"Background- Bronchial Asthma is a chronic inammatory disease of airways of lungs. It is characterized\nby various and recurring symptoms reversible airow obstruction and Bronchospasm. Modern science\nhas developed many medicines like Doxophylline, Theophylline, various Corticosteroids, and Salbutamol. Yet these medicines\ncome up with many adverse effects and they are also target specic. In Ayurveda Bronchial asthma is co-related with Tamaka\nShvasa. Tamaka Shvasa is mainly caused due to the Vata and Kapha Dosha. Hence in management of Tamaka Shvasa,\nVataghna and Kaphagna Chikita are needed. Kantakari is Vata-Kaphagna in nature. The drug is used as anti-asthmatics,\nhypoglycemic, anti-histaminics, anti-inammatory, anti-spasmodic, hypotensive, anti-pyretic activity. Case series of Methods10 patients were managed with Kantakari Siddha Ghruta Snehapana followed by Virechana and Shamana Chikitsa.\nAssessement was done on the basis of PFT and IgE. Improvement in PFT and Decreased IgE level w Result- ill be stated in full\npaper. After administration of Kantakari Sidha Ghruta, Virechana and Shamana Chikitsa, Discussion And Conclusionchanges in PFT observed with changes in IgE, which is mention in full paper. ON this we concluded that Ayurvedic treatment is\nbenecial in treatment of Tamaka Shvasa.","PeriodicalId":12664,"journal":{"name":"Global journal for research analysis","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2024-01-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Global journal for research analysis","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.36106/gjra/6705981","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 0

Abstract

Background- Bronchial Asthma is a chronic inammatory disease of airways of lungs. It is characterized by various and recurring symptoms reversible airow obstruction and Bronchospasm. Modern science has developed many medicines like Doxophylline, Theophylline, various Corticosteroids, and Salbutamol. Yet these medicines come up with many adverse effects and they are also target specic. In Ayurveda Bronchial asthma is co-related with Tamaka Shvasa. Tamaka Shvasa is mainly caused due to the Vata and Kapha Dosha. Hence in management of Tamaka Shvasa, Vataghna and Kaphagna Chikita are needed. Kantakari is Vata-Kaphagna in nature. The drug is used as anti-asthmatics, hypoglycemic, anti-histaminics, anti-inammatory, anti-spasmodic, hypotensive, anti-pyretic activity. Case series of Methods10 patients were managed with Kantakari Siddha Ghruta Snehapana followed by Virechana and Shamana Chikitsa. Assessement was done on the basis of PFT and IgE. Improvement in PFT and Decreased IgE level w Result- ill be stated in full paper. After administration of Kantakari Sidha Ghruta, Virechana and Shamana Chikitsa, Discussion And Conclusionchanges in PFT observed with changes in IgE, which is mention in full paper. ON this we concluded that Ayurvedic treatment is benecial in treatment of Tamaka Shvasa.

查看原文本刊更多论文

病例系列：支气管哮喘的阿育吠陀治疗

背景- 支气管哮喘是一种慢性肺气道ammatory 疾病。其特征是出现各种反复发作的症状，可逆的气ow 道阻塞和支气管痉挛。现代科学开发了许多药物，如多茶碱、茶碱、各种皮质类固醇和沙丁胺醇。然而，这些药物会产生许多不良反应，而且它们也是针对特定c。在阿育吠陀中，支气管哮喘与 Tamaka Shvasa 相关。Tamaka Shvasa 主要是由 Vata 和 Kapha Dosha 引起的。因此，在治疗 Tamaka Shvasa 时，需要 Vataghna 和 Kaphagna Chikita。Kantakari 的性质是 Vata-Kaphagna。该药具有抗哮喘、降血糖、抗组胺、抗inammatory、抗痉挛、降血压、解热等作用。病例系列方法 10 名患者接受了 Kantakari Siddha Ghruta Snehapana 治疗，随后接受了 Virechana 和 Shamana Chikitsa 治疗。根据肺活量和 IgE 进行了评估，结果显示肺活量有所改善，IgE 水平有所下降。在服用 Kantakari Sidha Ghruta、Virechana 和 Shamana Chikitsa 后，PFT 发生了变化，IgE 也发生了变化。由此，我们得出结论，阿育吠陀疗法是治疗 Tamaka Shvasa 的本cial。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Global journal for research analysis

自引率

0.00%

发文量